Skip To Main Content
Barbara E. Stähli on Muck Rack

Barbara E. Stähli

As seen in: Nature, Wiley Online Library, MDPI, European Heart Journal - Cardiovascular Imaging, Diabetes Care Magazine, JACC (Journal of the American College of Cardiology), Canadian Journal of Cardiology, International Journal of Cardiology, RadcliffeCardiology.com, Parallax by Ankur Kalra
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara E.

Contact Barbara E., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Killip class at presentation and immediate versus staged multivessel PCI in patients with STEMI

|
By Philipp Jakob, Ferdinando Varbella, Axel Linke, Stephan B. Felix, Moritz Seiffert, Peter Nordbeck, Bernhard Witzenbichler, Irene M. Lang, Mirjam Kessler, Christian Marc Valina, Miklos Rohla, Matteo Vercellino, Luise Gaede, Julia Stehli, Alessandro Candreva, Francesco Paneni, Christian Templin, Matthias Schindler, Greca Zanda, Giorgio Quadri, Norman Mangner, Aurel Toma, Giulia Magnani, Peter Clemmensen, Thomas Münzel, P. Christian Schulze, Karl-Ludwig Laugwitz, Wolfgang Rottbauer, Kurt Huber, Franz-Josef Neumann, Steffen Schneider, Thomas Riemer, Franz Weidinger, Stephan Achenbach, Gert Richardt, Adnan Kastrati, Ian Ford, Frank Ruschitzka, Barbara E. Stähli, Rahel Kesterke, Alban Dibra, Marco Moccetti, Lorenz Bott-Flügel, Michael Würdinger, Manfred Wischnewsky
| Nature Verified
Abstract Patients with ST-segment elevation myocardial infarction (STEMI) and higher Killip class are at an increased risk of death. We sought to assess outcomes of an immediate or staged multivessel percutaneous coronary intervention (PCI) in patients with higher Killip class presenting with STEMI and multivessel coronary artery disease (MVD). We conducted a subgroup analysis of the MULTISTARS AMI trial with stratification of patients according to Killip classes.
Open in Who Shared Issue with article?

Cardiac troponin elevation and mortality in takotsubo syndrome: New insights from the international takotsubo registry

|
By Barbara E. Stähli, Matthias Schindler, Victor Schweiger, Victoria L. Cammann
| Wiley Online Library Verified
CONFLICT OF INTEREST STATEMENT B. S. has been supported by a donation of H.H. Sheikh Khalifa bin Hamad Al-Thani to the University of Zurich, Switzerland, and research grants to the institution from the OPO Foundation, the Iten-Kohaut Foundation, the German Center for Cardiovascular Research (DZHK), Boston Scientific, and Edwards Lifesciences. B. S. has received consulting and speaker fees from Boston Scientific and Abbott Vascular.
Open in Who Shared Issue with article?

ACC.24: FFR or Culprit-Only PCI in STEMI

|
By Felix Böhm, Barbara E. Stähli, Gilles Montalescot, Andrew P DeFillipis
| Parallax by Ankur Kalra
ACC.24 — Investigator, Dr Felix Böhm (Danderyd Hospital, SE) joins us to discuss the findings from a study investigating fractional flow reserve-guided complete or culprit-only percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (MI). 1542 patients were enrolled in the trial, who were randomized 1:1 to receive either FFR-guided PCI of non-culprit lesions during index hospitalisation, or initial conservative management of non-culprit lesions.
Open in Who Shared Issue with article?
See all 28 articles